Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

[From a pathogen's genome to an effective vaccine: the four-component meningococcal serogroup B vaccine].

Abad R, Martinón-Torres F, Santolaya ME, Banzhoff A, González-Inchausti C, Graña MG, Vázquez JA.

Rev Esp Quimioter. 2019 Jun;32(3):208-216. Epub 2019 May 30. Review. Spanish.

2.

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017.

Krone M, Gray S, Abad R, Skoczyńska A, Stefanelli P, van der Ende A, Tzanakaki G, Mölling P, João Simões M, Křížová P, Emonet S, Caugant DA, Toropainen M, Vazquez J, Waśko I, Knol MJ, Jacobsson S, Rodrigues Bettencourt C, Musilek M, Born R, Vogel U, Borrow R.

Euro Surveill. 2019 Apr;24(14). doi: 10.2807/1560-7917.ES.2019.24.14.1800245.

3.

Ten years of external quality assessment (EQA) of Neisseria gonorrhoeae antimicrobial susceptibility testing in Europe elucidate high reliability of data.

Cole MJ, Quaye N, Jacobsson S, Day M, Fagan E, Ison C, Pitt R, Seaton S, Woodford N, Stary A, Pleininger S, Crucitti T, Hunjak B, Maikanti P, Hoffmann S, Viktorova J, Buder S, Kohl P, Tzelepi E, Siatravani E, Balla E, Hauksdóttir GS, Rose L, Stefanelli P, Carannante A, Pakarna G, Mifsud F, Cassar RZ, Linde I, Bergheim T, Steinbakk M, Mlynarczyk-Bonikowska B, Borrego MJ, Shepherd J, Pavlik P, Jeverica S, Vazquez J, Abad R, Weiss S, Spiteri G, Unemo M.

BMC Infect Dis. 2019 Mar 25;19(1):281. doi: 10.1186/s12879-019-3900-z.

4.

A giant retroperitoneal liposarcoma with renal involvement: A case report and literature review.

Montenegro A, Varas M, Sánchez-Vizcaíno E, Naval J, Loras C, Abad R.

Gastroenterol Hepatol. 2019 Feb 13. pii: S0210-5705(19)30019-6. doi: 10.1016/j.gastrohep.2019.01.003. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30772091
5.

Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide.

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, Comanducci M, Lemos AP, Gorla MC, Křížová P, Mikula C, Mulhall R, Nissen M, Nohynek H, Simões MJ, Skoczyńska A, Stefanelli P, Taha MK, Toropainen M, Tzanakaki G, Vadivelu-Pechai K, Watson P, Vazquez JA, Rajam G, Rappuoli R, Borrow R, Medini D.

Vaccine. 2019 Feb 8;37(7):991-1000. doi: 10.1016/j.vaccine.2018.12.061. Epub 2019 Jan 17.

6.

Meningococcal serogroups and surveillance: a systematic review and survey.

Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH; Meningococcal Surveillance Group (in alphabetical order), Abad R, Bailey F, Garcia IF, Decheva A, Krizova P, Melillo T, Skoczynska A, Vladimirova N.

J Glob Health. 2019 Jun;9(1):010409. doi: 10.7189/jogh.09.010409.

7.

Differential diagnosis by RT-PCR of Bordetella bronchiseptica in a child without previous pathologic antecedents suffering whooping cough.

Sanz JC, Abad R, Sanz C, Miguel A.

Enferm Infecc Microbiol Clin. 2018 Nov 1. pii: S0213-005X(18)30280-5. doi: 10.1016/j.eimc.2018.09.016. [Epub ahead of print] English, Spanish. No abstract available.

PMID:
30392705
8.

Dynamic Atlas-based segmentation and quantification of Neuromelanin-rich brainstem structures in Parkinson disease.

Ariz M, Abad RC, Castellanos G, Martinez M, Munoz-Barrutia A, Fernandez-Seara MA, Pastor P, Pastor MA, Ortiz-de-Solorzano C.

IEEE Trans Med Imaging. 2018 Oct 1. doi: 10.1109/TMI.2018.2872852. [Epub ahead of print]

PMID:
30281440
9.

Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey.

Harris SR, Cole MJ, Spiteri G, Sánchez-Busó L, Golparian D, Jacobsson S, Goater R, Abudahab K, Yeats CA, Bercot B, Borrego MJ, Crowley B, Stefanelli P, Tripodo F, Abad R, Aanensen DM, Unemo M; Euro-GASP study group.

Lancet Infect Dis. 2018 Jul;18(7):758-768. doi: 10.1016/S1473-3099(18)30225-1. Epub 2018 May 15.

10.

Infections by emerging serogroups of Neisseria meningitidis: A case report.

Pérez-García F, Abad R, Almirall C, Abarca E.

Enferm Infecc Microbiol Clin. 2019 Feb;37(2):142-143. doi: 10.1016/j.eimc.2018.03.009. Epub 2018 May 1. English, Spanish. No abstract available.

PMID:
29724617
11.

Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine.

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, Jones TR, Li S, Zlotnick G, Vogel U, Claus H, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Wang X, Vuong J, Mayer LW, Pride MW, Jansen KU, Anderson AS.

MBio. 2018 Mar 13;9(2). pii: e00036-18. doi: 10.1128/mBio.00036-18.

12.

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.

Abad R, Medina V, Fariñas MDC, Martínez-Martínez L, Bambini S, Dari A, Medini D, Pizza M, Vázquez JA.

J Infect. 2017 Dec;75(6):511-520. doi: 10.1016/j.jinf.2017.09.021. Epub 2017 Oct 5.

PMID:
28987549
13.

Should we continue to monitor 4CMenB coverage with MATS?

Abad R, Vazquez J.

Lancet Infect Dis. 2017 Jul;17(7):681-683. doi: 10.1016/S1473-3099(17)30174-3. Epub 2017 Mar 30. No abstract available.

PMID:
28366724
14.

Two Cases of Neisseria meningitidis Proctitis in HIV-Positive Men Who Have Sex with Men.

Gutierrez-Fernandez J, Medina V, Hidalgo-Tenorio C, Abad R.

Emerg Infect Dis. 2017 Mar;23(3):542-543. doi: 10.3201/eid2303.161039.

15.

The Effects of One-Anastomosis Gastric Bypass on Glucose Metabolism in Goto-Kakizaki Rats.

Zubiaga L, Abad R, Ruiz-Tovar J, Enriquez P, Vílchez JA, Calzada M, Pérez De Gracia JA, Deitel M.

Obes Surg. 2016 Nov;26(11):2622-2628.

PMID:
26989061
16.

WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014.

Jacobsson S, Golparian D, Cole M, Spiteri G, Martin I, Bergheim T, Borrego MJ, Crowley B, Crucitti T, Van Dam AP, Hoffmann S, Jeverica S, Kohl P, Mlynarczyk-Bonikowska B, Pakarna G, Stary A, Stefanelli P, Pavlik P, Tzelepi E, Abad R, Harris SR, Unemo M.

J Antimicrob Chemother. 2016 Nov;71(11):3109-3116. Epub 2016 Jul 17.

PMID:
27432597
17.

Early evidence of expanding W ST-11 CC meningococcal incidence in Spain.

Abad R, Vázquez JA.

J Infect. 2016 Sep;73(3):296-7. doi: 10.1016/j.jinf.2016.06.010. Epub 2016 Jul 5. No abstract available.

PMID:
27387450
18.

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European Countries.

Abad R, Medina V, Stella M, Boccadifuoco G, Comanducci M, Bambini S, Muzzi A, Vázquez JA.

PLoS One. 2016 Mar 7;11(3):e0150721. doi: 10.1371/journal.pone.0150721. eCollection 2016.

19.

[Previous pathology in cases of invasive meningococcal disease in children under 5 years old].

Abad R, Cano R, Thuissard IJ, Vázquez JA.

Gac Sanit. 2015 Nov-Dec;29(6):475-6. doi: 10.1016/j.gaceta.2015.08.003. Epub 2015 Sep 26. Spanish. No abstract available.

20.

A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.

Abad R, Biolchi A, Moschioni M, Giuliani MM, Pizza M, Vázquez JA.

Clin Vaccine Immunol. 2015 Apr;22(4):357-60. doi: 10.1128/CVI.00669-14. Epub 2015 Jan 28.

21.

[Polyvalent meningococcal vaccines: within or outside our agenda?].

Abad R, Vázquez JA.

An Pediatr (Barc). 2014 Nov;81(5):329.e1-7. doi: 10.1016/j.anpedi.2014.06.015. Epub 2014 Jul 25. Spanish.

22.

Optimizing strategies for meningococcal C disease vaccination in Valencia (Spain).

Pérez-Breva L, Villanueva RJ, Villanueva-Oller J, Acedo L, Santonja F, Moraño JA, Abad R, Vázquez JA, Díez-Domingo J.

BMC Infect Dis. 2014 May 21;14:280. doi: 10.1186/1471-2334-14-280.

23.

Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America.

Abad R, López EL, Debbag R, Vázquez JA.

Epidemiol Infect. 2014 Dec;142(12):2461-70. doi: 10.1017/S0950268814001149. Epub 2014 May 15.

PMID:
24831052
24.

Effectiveness of meningococcal serogroup C vaccine programmes.

Borrow R, Abad R, Trotter C, van der Klis FR, Vazquez JA.

Vaccine. 2013 Sep 23;31(41):4477-86. doi: 10.1016/j.vaccine.2013.07.083. Epub 2013 Aug 9. Review.

PMID:
23933336
25.

A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups.

Hoiseth SK, Murphy E, Andrew L, Vogel U, Frosch M, Hellenbrand W, Abad R, Vazquez JA, Borrow R, Findlow J, Taha MK, Deghmane AE, Caugant DA, Kriz P, Musilek M, Mayer LW, Wang X, Macneil JR, York L, Tan CY, Jansen KU, Anderson AS.

Pediatr Infect Dis J. 2013 Oct;32(10):1096-101. doi: 10.1097/INF.0b013e31829aa63b.

PMID:
23694830
26.

Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial).

Martín-Lesende I, Orruño E, Bilbao A, Vergara I, Cairo MC, Bayón JC, Reviriego E, Romo MI, Larrañaga J, Asua J, Abad R, Recalde E.

BMC Health Serv Res. 2013 Mar 28;13:118. doi: 10.1186/1472-6963-13-118.

27.

Early management of type 2 diabetes based on a SMBG strategy: the way to diabetes regression--the St Carlos study : a 3-year, prospective, randomized, clinic-based, interventional study with parallel groups.

García de la Torre N, Durán A, Del Valle L, Fuentes M, Barca I, Martín P, Montañez C, Perez-Ferre N, Abad R, Sanz F, Galindo M, Rubio MA, Calle-Pascual AL.

Acta Diabetol. 2013 Aug;50(4):607-14. doi: 10.1007/s00592-013-0467-9. Epub 2013 Mar 27.

PMID:
23532298
28.

Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment.

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, Caugant DA, Kriz P, Abad R, Bambini S, Carannante A, Deghmane AE, Fazio C, Frosch M, Frosi G, Gilchrist S, Giuliani MM, Hong E, Ledroit M, Lovaglio PG, Lucidarme J, Musilek M, Muzzi A, Oksnes J, Rigat F, Orlandi L, Stella M, Thompson D, Pizza M, Rappuoli R, Serruto D, Comanducci M, Boccadifuoco G, Donnelly JJ, Medini D, Borrow R.

Lancet Infect Dis. 2013 May;13(5):416-25. doi: 10.1016/S1473-3099(13)70006-9. Epub 2013 Feb 13.

PMID:
23414709
29.

Target gene sequencing to define the susceptibility of Neisseria meningitidis to ciprofloxacin.

Hong E, Thulin Hedberg S, Abad R, Fazio C, Enríquez R, Deghmane AE, Jolley KA, Stefanelli P, Unemo M, Vazquez JA, Veyrier FJ, Taha MK.

Antimicrob Agents Chemother. 2013 Apr;57(4):1961-4. doi: 10.1128/AAC.02184-12. Epub 2013 Jan 28.

30.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

31.

[Neisseria meningitidis serogroup Y infection with an atypical clinical presentation and diagnosis].

Aspiroz C, Abad R, Laguardia P, Vázquez JA.

Enferm Infecc Microbiol Clin. 2012 Nov;30(9):580-1. doi: 10.1016/j.eimc.2012.04.002. Epub 2012 May 29. Spanish. No abstract available.

PMID:
22652099
32.

[Microbiology and public health: new challenges in surveillance and control of meningococcal disease].

Abad R, Vázquez JA.

Enferm Infecc Microbiol Clin. 2012 Feb;30(2):53-5. doi: 10.1016/j.eimc.2012.01.002. Spanish. No abstract available.

PMID:
22305483
33.

Using scalp electrical biosignals to control an object by concentration and relaxation tasks: design and evaluation.

George L, Lotte F, Abad RV, Lécuyer A.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6299-302. doi: 10.1109/IEMBS.2011.6091554.

PMID:
22255778
34.

How do hatcheries influence embryonic development of sea turtle eggs? Experimental analysis and isolation of microorganisms in leatherback turtle eggs.

Patino-Martinez J, Marco A, Quiñones L, Abella E, Abad RM, Diéguez-Uribeondo J.

J Exp Zool A Ecol Genet Physiol. 2012 Jan 1;317(1):47-54. doi: 10.1002/jez.719. Epub 2011 Oct 21.

PMID:
22021044
35.

[Assessment of the surgical risk of 1,000 consecutive episodes using the POSSUM system. Comparison between elective and emergency gastrointestinal surgery].

Villodre C, Carbonell S, Espinosa J, Bravo JA, Zubiaga L, Rojas S, Abad R, Campos L, Alcázar C, Franco M, Estrada JL, Zapater P, Mena L, Lluís F.

Cir Esp. 2012 Jan;90(1):24-32. doi: 10.1016/j.ciresp.2011.06.004. Epub 2011 Sep 3. Spanish.

PMID:
21890122
36.

Outcome after partial medial meniscus substitution with the collagen meniscal implant at a minimum of 10 years' follow-up.

Monllau JC, Gelber PE, Abat F, Pelfort X, Abad R, Hinarejos P, Tey M.

Arthroscopy. 2011 Jul;27(7):933-43. doi: 10.1016/j.arthro.2011.02.018. Epub 2011 May 31.

PMID:
21621373
37.

Assessment of a primary care-based telemonitoring intervention for home care patients with heart failure and chronic lung disease. The TELBIL study.

Martín-Lesende I, Orruño E, Cairo C, Bilbao A, Asua J, Romo MI, Vergara I, Bayón JC, Abad R, Reviriego E, Larrañaga J.

BMC Health Serv Res. 2011 Mar 8;11:56. doi: 10.1186/1472-6963-11-56.

38.

Usefulness of endoscopic ultrasonography (EUS) for selecting carcinoid tumors as candidates to endoscopic resection.

Varas MJ, Gornals JB, Pons C, Espinós JC, Abad R, Lorente FJ, Bargalló D.

Rev Esp Enferm Dig. 2010 Oct;102(10):577-82.

39.

Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: the St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups.

Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M, Del Valle L, Sanz MF, Calle-Pascual AL.

J Diabetes. 2010 Sep;2(3):203-11. doi: 10.1111/j.1753-0407.2010.00081.x.

40.

Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing.

Taha MK, Hedberg ST, Szatanik M, Hong E, Ruckly C, Abad R, Bertrand S, Carion F, Claus H, Corso A, Enríquez R, Heuberger S, Hryniewicz W, Jolley KA, Kriz P, Mollerach M, Musilek M, Neri A, Olcén P, Pana M, Skoczynska A, Sorhouet Pereira C, Stefanelli P, Tzanakaki G, Unemo M, Vázquez JA, Vogel U, Wasko I.

Antimicrob Agents Chemother. 2010 Sep;54(9):3651-8. doi: 10.1128/AAC.00315-10. Epub 2010 Jul 6.

41.

Deletion of the Correia element in the mtr gene complex of Neisseria meningitidis.

Enríquez R, Abad R, Chanto G, Corso A, Cruces R, Gabastou JM, Gorla MC, Maldonado A, Moreno J, Muros-Le Rouzic E, Sorhouet C, Vázquez JA.

J Med Microbiol. 2010 Sep;59(Pt 9):1055-60. doi: 10.1099/jmm.0.021220-0. Epub 2010 Jun 10.

PMID:
20538893
42.

New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae.

Galarza PG, Abad R, Canigia LF, Buscemi L, Pagano I, Oviedo C, Vázquez JA.

Antimicrob Agents Chemother. 2010 Apr;54(4):1652-3. doi: 10.1128/AAC.01506-09. Epub 2010 Feb 1. No abstract available.

43.

[Improving the specification quality of inclusion criteria of patients in chemotherapy clinical trials].

Real JM, Agustín MA, Serrano MC, Idoipe A, Palomo P, Abad R.

Rev Calid Asist. 2009 Nov-Dec;24(6):280-6. doi: 10.1016/j.cali.2009.07.003. Epub 2009 Oct 3. Spanish.

PMID:
19800829
44.

Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region.

Abad R, Agudelo CI, Brandileone MC, Chanto G, Gabastou JM, Hormazabal JC, O Gorla MC, Maldonado A, Moreno J, Muros-Le Rouzic E, Lersch R, Regueira M, Salcedo C, Sorhouet C, Vázquez JA.

J Infect. 2009 Aug;59(2):104-14. doi: 10.1016/j.jinf.2009.06.001. Epub 2009 Jun 11.

PMID:
19576638
45.

W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.

Efron AM, Sorhouet C, Salcedo C, Abad R, Regueira M, Vázquez JA.

J Clin Microbiol. 2009 Jun;47(6):1979-80. doi: 10.1128/JCM.02390-08. Epub 2009 Apr 8. No abstract available.

46.

B:2a:p1.5 meningococcal strains likely arisen from capsular switching event still spreading in Spain.

Castilla J, Vázquez JA, Salcedo C, García Cenoz M, García Irure JJ, Torroba L, Beristain X, Abad R, Barricarte A.

J Clin Microbiol. 2009 Feb;47(2):463-5. doi: 10.1128/JCM.01495-08. Epub 2008 Dec 17.

47.

Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.

Enríquez R, Abad R, Salcedo C, Vázquez JA.

Antimicrob Agents Chemother. 2009 Feb;53(2):796-7. doi: 10.1128/AAC.00531-08. Epub 2008 Nov 17.

48.

A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies.

Uria MJ, Zhang Q, Li Y, Chan A, Exley RM, Gollan B, Chan H, Feavers I, Yarwood A, Abad R, Borrow R, Fleck RA, Mulloy B, Vazquez JA, Tang CM.

J Exp Med. 2008 Jun 9;205(6):1423-34. doi: 10.1084/jem.20072577. Epub 2008 May 26.

49.

PorB2/3 protein hybrid in Neisseria meningitidis.

Abad R, Enríquez R, Salcedo C, Vázquez JA.

Emerg Infect Dis. 2008 Apr;14(4):688-9. doi: 10.3201/eid1404.070869. No abstract available.

50.

Fluoroquinolone resistance in Neisseria meningitidis in Spain.

Enríquez R, Abad R, Salcedo C, Pérez S, Vázquez JA.

J Antimicrob Chemother. 2008 Feb;61(2):286-90. Epub 2007 Nov 20.

PMID:
18032423

Supplemental Content

Support Center